$Armata Pharmaceuticals (ARMP.US)$Reuters· 5 mins ago Armata Pharmaceuticals Receives $5.25 Million of Additional Non-Dilutive Grant Funding From the U.S. Department of Defense to Support Ongoing Disarm Clinical Trial of AP-SA02
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more